Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianhua Chao

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Neuroimmunology|May 26, 2015
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent mannerGeoffrey O Gillard, Brian Collette, John Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonistsGaifa Lai, J Robert Merritt, Zhenmin He, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonistsTao Wang, Daliya Banerjee, Tonika Bohnert, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2016
Discovery of biaryls as RORγ inverse agonists by using structure-based designIstvan J Enyedy, Noel A Powell, Justin Caravella, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonistWaldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonistsPurakkattle Biju, Arthur Taveras, Younong Yu, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitorsAlexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Immunology|December 24, 2015
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivoDaliya Banerjee, Linlin Zhao, Lan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Neuroimmunology|May 26, 2015
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent mannerGeoffrey O Gillard, Brian Collette, John Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonistsGaifa Lai, J Robert Merritt, Zhenmin He, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonistsTao Wang, Daliya Banerjee, Tonika Bohnert, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2016
Discovery of biaryls as RORγ inverse agonists by using structure-based designIstvan J Enyedy, Noel A Powell, Justin Caravella, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonistWaldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonistsPurakkattle Biju, Arthur Taveras, Younong Yu, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitorsAlexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Immunology|December 24, 2015
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivoDaliya Banerjee, Linlin Zhao, Lan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.
Pageof 2